These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 6304848

  • 1. [Response of Mycobacteria tuberculosis isolated from chronic patients to single or combined drugs].
    Fanea E, Vaida T, Buzilă A, Bukşe E, Câmpeanu L.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):335-42. PubMed ID: 6304848
    [No Abstract] [Full Text] [Related]

  • 2. [In vitro activities of antitubercular agents and intensification of combined chemotherapy of tuberculosis].
    Ooizumi K.
    Kekkaku; 1983 Sep; 58(9):490-2. PubMed ID: 6420602
    [No Abstract] [Full Text] [Related]

  • 3. [Main sources of the formation of contingents of tuberculosis patients with drug-resistant or sensitive Mycobacterium tuberculosis isolates].
    Zhukova MP.
    Probl Tuberk; 1998 Sep; (4):4-5. PubMed ID: 9771024
    [Abstract] [Full Text] [Related]

  • 4. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
    Bialik IB, Klimenko MT.
    Probl Tuberk; 1980 Oct; (10):68-70. PubMed ID: 6776517
    [No Abstract] [Full Text] [Related]

  • 5. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
    Khomenko AG, Chukanov VI, Korneev AA.
    Probl Tuberk; 1996 Oct; (6):42-4. PubMed ID: 9019768
    [Abstract] [Full Text] [Related]

  • 6. [Infection due to drug-resistant mycobacteria].
    D'Alfonso G, Micillo E.
    Lotta Tuberc; 1972 Oct; 42(1):134-9. PubMed ID: 4626198
    [No Abstract] [Full Text] [Related]

  • 7. [Frequency and clinical importance of primary pharmacoresistance of Mycobacteria in patients with tuberculosis of the lungs].
    Bibik NF.
    Probl Tuberk; 1972 Oct; 50(8):20-5. PubMed ID: 4626690
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Ethambutol in the treatment of chronic pulmonary tuberculosis in patients excreting organisms resistant to several antitubercular agents].
    Bek-Lissner E, Rózewska M.
    Gruzlica; 1971 Jul; 39(7):643-7. PubMed ID: 5000656
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical and bacteriological aspects of the drug resistance of Mycobacterium tuberculosis in patients with chronic destructive pulmonary tuberculosis].
    Korotaev GA, Kozulitsyna TI, Tret'iakova EA, Mamed'iarova FA.
    Probl Tuberk; 1986 Jul; (7):32-6. PubMed ID: 3094001
    [No Abstract] [Full Text] [Related]

  • 12. [Epidemiologic aspects of resistance to ATA (Antitubercular Agents)].
    Zrilić V, Muzikravić T.
    Plucne Bolesti Tuberk; 1974 Jul; 26 Suppl 2():29-37. PubMed ID: 4216919
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Resistance of tuberculosis mycobacteria isolated from resected lungs].
    Usov II, Belousov AV.
    Probl Tuberk; 1967 Jul; 45(12):68. PubMed ID: 4974358
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Primary resistance to antitubercular drugs].
    Caminero Luna JA.
    Med Clin (Barc); 1989 Jun 03; 93(1):30-6. PubMed ID: 2505005
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.